Newsmeme!
Discover News you didn't know existed
Are your hormones out of balance? Does your life feel like a song played badly out of tune? If so, the problem may have to...
NEW YORK----Reportlinker.com announces that a new market research report is available in its catalogue.
By Helen Massy-Beresford and Ben Hirschler
{{a href="external_link-1085522"}}GlaxoSmithKline’s{{/a}} hopes that its troubled diabetes drug Avandia would prove effective against Alzheimer’s have been dashed, Bloomberg news reports.
July 13 (Bloomberg) -- The following is a list of companies whose shares may have unusual price changes in U.K. and Irish markets today. Stock symbols are in parentheses and prices are from the last market close.
July 12 (Bloomberg) -- GlaxoSmithKline Plc ’s diabetes drug Avandia failed to benefit patients with Alzheimer’s disease, according to a company-funded study.
Shares of Amylin Pharmaceuticals Inc. jumped Wednesday after the company said the Food and Drug Administration will review the potential once-weekly diabetes drug exenatide LAR.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |